RAPT Historical Cash Flow
| RAPT Stock | USD 1.23 0.11 9.82% |
Analysis of RAPT Therapeutics cash flow over time is an excellent tool to project RAPT Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 5.8 M or Begin Period Cash Flow of 36.8 M as it is a great indicator of RAPT Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining RAPT Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether RAPT Therapeutics is a good buy for the upcoming year.
RAPT |
About RAPT Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in RAPT balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which RAPT's non-liquid assets can be easily converted into cash.
RAPT Therapeutics Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by RAPT Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of RAPT Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from RAPT Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into RAPT Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RAPT Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy RAPT Stock please use our How to Invest in RAPT Therapeutics guide.At this time, RAPT Therapeutics' Sale Purchase Of Stock is comparatively stable compared to the past year. Investments is likely to gain to about 44.3 M in 2024, whereas Total Cashflows From Investing Activities is likely to drop (43 M) in 2024.
RAPT Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
RAPT Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
RAPT Therapeutics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 802K | 896K | 141.5M | 131.2M | 150.9M | 158.4M | |
| Investments | (843K) | (87.0M) | (80.6M) | (44.6M) | 42.2M | 44.3M | |
| Change In Cash | 13.6M | (52.5M) | (891K) | 14.9M | 8.5M | 9.0M | |
| Stock Based Compensation | 2.1M | 8.7M | 10.0M | 11.3M | 17.1M | 17.9M | |
| Free Cash Flow | (36.4M) | (40.9M) | (61.8M) | (71.6M) | (98.2M) | (93.3M) | |
| Change In Working Capital | 4.1M | 2.3M | (4.3M) | (1.3M) | 5.5M | 5.8M | |
| Begin Period Cash Flow | 63.8M | 77.4M | 24.9M | 24.0M | 38.9M | 36.8M | |
| Total Cashflows From Investing Activities | (843K) | (87.4M) | (81.3M) | (45.5M) | (40.9M) | (43.0M) | |
| Other Cashflows From Financing Activities | 49.9M | 1.9M | 2.0M | 1.4M | 1.4M | 1.4M | |
| Depreciation | 1.3M | 1.1M | 996K | 1.0M | 1.2M | 952.3K | |
| Other Non Cash Items | 20K | 248K | 1.5M | 2.1M | (4.1M) | (3.9M) | |
| Capital Expenditures | 888K | 398K | 755K | 845K | 1.1M | 986.9K | |
| Total Cash From Operating Activities | (35.5M) | (40.5M) | (61.0M) | (70.8M) | (97.0M) | (92.2M) | |
| Change To Operating Activities | (603K) | (1.0M) | (1.8M) | (3.5M) | (3.2M) | (3.0M) | |
| Net Income | (43.0M) | (52.9M) | (69.2M) | (83.8M) | (116.8M) | (111.0M) | |
| Total Cash From Financing Activities | 49.9M | 75.5M | 141.5M | 131.2M | 1.4M | 1.4M | |
| End Period Cash Flow | 77.4M | 24.9M | 24.0M | 38.9M | 47.5M | 37.0M | |
| Change To Netincome | 2.1M | 8.4M | 11.5M | 11.9M | 13.7M | 14.4M | |
| Change To Liabilities | 4.7M | 3.3M | (2.5M) | 2.2M | 2.0M | 1.2M | |
| Issuance Of Capital Stock | 49.9M | 74.6M | 139.5M | 129.8M | 75.0M | 95.6M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RAPT Stock Analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.